Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
World Cancer Day
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Access
All
Content accessible to Me
Refine by Date
From
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
—
To
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://jnccn.org/browse?access=all&page=9&pageSize=10&sort=datedescending
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Browse
You are looking at
81
-
90
of
3,812
items for
Refine by Access: All
x
Clear All
Items per page
10
20
50
Sort by
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
4
5
6
7
8
9
10
11
12
13
14
...
Full access
CLO22-052: A Tale of Two Schedules: A Study of the Efficacy and Toxicity Outcomes of Extended Durvalumab Dosing in Patients with Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)
Lilian Hanna, Gordon Taylor Moffat, Wilma Hopman, Pierre-Olivier Gaudreau, and Andrea S. Fung
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-053: Risk Factors of Paclitaxel Induced Peripheral Neuropathy in Early Breast Cancer Patient in Relation to Mean Changes of Neuropathy Growth Factors and Serum Malondialdehyde
Rasha Abo El Hassan, Noura Anwar Abdel-Fatah, Hadeer Khalefa Ahmed, May Shawki, and Lamia El Wkeel
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-054: A Pilot Study of Liquid Biopsy Utility in De-escalation Therapy for HPV-Associated Oropharyngeal Cancer
Christopher John Hughes, Thom Loree, Mark Burke, Michael Nagai, Nabil Alam, Daniel Ford, and James Zemer
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-055: Breast Cancer in Men: Experiences of Men With Breast Cancer in One of the Largest Hospital in Riyadh, KSA
Manal AL Al Humaid, Mohammed Amin, Ahmed Al Qudaimat, Lolwah Alriyees, Carmen Vasilescu, and Hussam Shehata
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-056: Phase I Trial of Concurrent Nab-paclitaxel and Cisplatin With Radiotherapy for Locally Advanced Cervical Cancer
Ping Jiang, Ang Qu, Weijuan Jiang, Xiuwen Deng, and Junjie Wang
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-057: A Rare Case of Intravascular Lymphoma Presenting With Dyspnea and Bilateral Lung Infiltrates
Imad Karam and Meera Rana
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-058: Sex Differences in Pain Relief From Medical Cannabis in Patients With Cancer: Results From the Quebec Cannabis Registry
Popi Kasvis, Yasmina Hachem, Helene Kim, Robert Kilgour, and Antonio Vigano
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-059: Chemotherapy Timing and Outcomes in Early Breast Cancer
Kristen Kelley, Audrey York, Benjamin Haaland, Xuechen Wang, Shiven Patel, Adriana Coletta, and Christos Vaklavas
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-060: > 3 Courses of Neo-Adjuvant Chemotherapy (NACT) May Affect Outcomes of Advanced Ovarian Serous Adenocarcinoma Patients
Yunyun Liu, KKL Chan, and Hui Zhou
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Full access
CLO22-061: c-MET Alteration in Patients With Metastasized Colorectal Carcinoma – An Evaluation of Methods of Detection, Clinical Impact and Discussion of c-MET as Potential Therapeutic Target
Amelie Lueders, Annalen Bleckmann, Tim Beißbarth, and Hans-Ulrich Schildhaus
In
Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference
31 Mar 2022
Items per page
10
20
50
Sort by
Article A - Z
Article Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
4
5
6
7
8
9
10
11
12
13
14
...
[3.239.129.91]
3.239.129.91
